356 result(s) found for: Agonists.
Displaying page 1 of 18.
| EudraCT Number: 2021-000610-42 | Sponsor Protocol Number: VUmc_2021-5021 | Start Date*: 2021-05-03 |
| Sponsor Name:Amsterdam UMC - location VUmc | ||
| Full Title: Dynamic and test-retest whole body [18F]FES PET imaging in patients with metastatic ER+ breast cancer. | ||
| Medical condition: Metastatic ER+ breast cancer. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-002391-97 | Sponsor Protocol Number: PML_DOC_0802 | Start Date*: 2008-06-19 |
| Sponsor Name:University Hospital Antwerp; Department Respiratory Medicine | ||
| Full Title: Open-label, prospective study to assess the effects of formoterol and beclometasone dipropionate combination therapy on central and peripheral airway dimensions in asthmatic patients | ||
| Medical condition: Asthma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-004060-24 | Sponsor Protocol Number: Glaucoma Xalacam /Combigan | Start Date*: 2005-11-24 |
| Sponsor Name:Department of Clinical Pharmacology | ||
| Full Title: A double-masked randomized cross-over study comparing the effect of Xalacom (latanoprost/timolol) and Combigan (brimonidine/timolol) fixed combination on intraocular pressure and ocular blood flow ... | ||
| Medical condition: Glaucoma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-003066-32 | Sponsor Protocol Number: CQBX258X2201 | Start Date*: 2012-02-09 | |||||||||||
| Sponsor Name:Novartis Pharma Services AG | |||||||||||||
| Full Title: A randomized double-blind multiple-dose placebo-controlled trial to establish the efficacy of QBX258 (combination of VAK694 and QAX576) in asthma that is inadequately controlled with inhaled cortic... | |||||||||||||
| Medical condition: Patients with asthma that are inadequately controlled with inhaled corticosteroids and long acting beta agonists | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-000683-84 | Sponsor Protocol Number: 05-FOR-02 | Start Date*: 2006-05-10 |
| Sponsor Name:Andi-Ventis Ltd. | ||
| Full Title: A DOUBLE BLIND, DOUBLE DUMMY, GROUP COMPARATIVE STUDY TO ASSESS THERAPEUTIC EQUIVALENCE OF A NEW GENERIC FORMOTEROL 12 uG DRY POWDER FORMULATION WITH OXIS 12uG TURBUHALER IN ADOLESCENT AND ADULT AS... | ||
| Medical condition: asthma bronchiale | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: HU (Completed) SK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-003991-39 | Sponsor Protocol Number: I-025 | Start Date*: 2005-12-08 |
| Sponsor Name:insaf, Institut für Atemwegsforschung GmbH | ||
| Full Title: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL CROSSOVER TRIAL IN ADULT ASTHMATICS EVALUATING THE EFFECT OF CONCOMITANT TWO WEEKS TREATMENT WITH MONTELUKAST (SINGULAIR™) 10 MG ONCE DAILY OR ... | ||
| Medical condition: Intermittend or mild asthma according to the definition of the Global Initiative ofor Asthma (GINA) guidelines step 1 or step 2 (2004) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-003981-42 | Sponsor Protocol Number: 2012.2708 | Start Date*: 2014-10-20 |
| Sponsor Name:University Medical Center Groningen [...] | ||
| Full Title: Estrogen receptor and androgen receptor imaging in metastatic breast cancer patients | ||
| Medical condition: Estrogen receptor positive metastatic breast cancer patients | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-001398-44 | Sponsor Protocol Number: PR 2006-04 | Start Date*: 2006-06-13 |
| Sponsor Name:Barts and The London NHS Trust | ||
| Full Title: The use of Peroxisome Proliferator Activator Receptor Agonists in the management of Androgen Independent Prostate Cancer | ||
| Medical condition: The use of Peroxisome Proliferator Activator Receptor Agonists in the management of Androgen Independent Prostate Cancer. Open-labeled, non-randomised clinical trial in patients with androgen indep... | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-002538-37 | Sponsor Protocol Number: PCH05-01 | Start Date*: 2005-08-05 |
| Sponsor Name:Pharmachemie B.V. | ||
| Full Title: Randomised, double-blind study to demonstrate therapeutic equivalence of formoterol fumarate 12µg capsules delivered by Cyclohaler with Foradil in mild to moderate reversible obstructive airways ... | ||
| Medical condition: mild to moderate reversible obstructive airways disease | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-004296-35 | Sponsor Protocol Number: RGHT000203 | Start Date*: 2007-10-18 |
| Sponsor Name:The Royal Group of Hospitals, Belfast Health and Social Care Trust [...] | ||
| Full Title: An investigation into the modulation of obesity associated monocyte/macrophage function, vascular inflammation and insulin resistance by PPAR agonist treatment | ||
| Medical condition: The proposed study will investigate early indicators of cardiovascular disease and diabetes in healthy, obese men without a family history of diabetes and whether these are changed by treatment wit... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-003377-15 | Sponsor Protocol Number: ERASMUS2007,Sofia2 | Start Date*: 2007-08-30 |
| Sponsor Name:Erasmus Hospital | ||
| Full Title: Chemoreflex sensitivity, exercise and beta agonists | ||
| Medical condition: Healthy participants | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-005855-14 | Sponsor Protocol Number: C2L-OCT-01 PR-301 | Start Date*: 2007-02-22 |
| Sponsor Name:Ambrilia Biopharma Inc. | ||
| Full Title: OPEN LABEL, RANDOMIZED STUDY COMPARING THE BIOLOGICAL EFFICACY AND SAFETY OF A NEW PROLONGED RELEASE FORMULATION OF OCTREOTIDE ACETATE, C2L-OCT-01 PR, 30 MG ADMINISTERED INTRA MUSCULARLY EVERY 42 D... | ||
| Medical condition: Acromegaly | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: HU (Completed) SK (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-015833-66 | Sponsor Protocol Number: 50/0811 | Start Date*: 2009-01-20 | |||||||||||
| Sponsor Name:CASA DI CURA PRIVATA S.RAFFAELE - PISANA | |||||||||||||
| Full Title: Ropinirole 24h prolonged release and motor fluctuations: a study to control the wearing-off induced by dopamine agonists immediate release | |||||||||||||
| Medical condition: Parkinson's Disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-001247-12 | Sponsor Protocol Number: 20-001 | Start Date*: 2021-03-30 | |||||||||||
| Sponsor Name:University Medical Center Groningen | |||||||||||||
| Full Title: An Open Label, Phase IV, Mechanistic, Study to Evaluate the Natriuretic Effect of 2-Week Dapagliflozin treatment in Type 2 Diabetes Mellitus Patients with Impaired Renal Function | |||||||||||||
| Medical condition: Type 2 diabetes mellitus (T2DM) with impaired renal function | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-023996-25 | Sponsor Protocol Number: 26081985 | Start Date*: 2010-12-21 |
| Sponsor Name: | ||
| Full Title: The effect of fluoxetine and 5-HT4 serotonin receptor agonists on cerebral axonal energy metabolism and glutamate levels in multiple sclerosis. | ||
| Medical condition: Multiple sclerosis (both relapsing remitting and progressive forms) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-002163-84 | Sponsor Protocol Number: BY9010/M1-145 | Start Date*: 2005-07-18 | |||||||||||
| Sponsor Name:ALTANA Pharma AG | |||||||||||||
| Full Title: Comparison of the Efficacy and Safety of 160 µg Ciclesonide Administered Once Daily in the Evening with or without Different Spacer Types in Patients with Asthma A randomized, open-label, three-ar... | |||||||||||||
| Medical condition: asthma bronchial | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Completed) IT (Prematurely Ended) DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-004756-20 | Sponsor Protocol Number: EFC6546 | Start Date*: 2007-09-19 |
| Sponsor Name:sanofi-aventis recherche & développement | ||
| Full Title: A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Aflibercept Versus Placebo Administered Every 3 Weeks in Patients Treated with Docetaxel / Prednisone for Metastat... | ||
| Medical condition: Patients with metastatic androgen-independent prostate cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: FR (Completed) SE (Completed) CZ (Completed) PT (Completed) ES (Completed) DK (Completed) HU (Completed) EE (Completed) BE (Completed) NL (Completed) IT (Completed) DE (Completed) GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-006033-32 | Sponsor Protocol Number: S308.3.001 | Start Date*: 2006-04-20 |
| Sponsor Name:Solvay Pharmaceuticals | ||
| Full Title: A Randomized, Double-blind, Placebo Controlled Parallel-group Fixed and Flexible SLV308 Dose Arm Study to Assess Efficacy and Safety of SLV308 Monotherapy in the Treatment of Patients with Early St... | ||
| Medical condition: Parkinson's Disease Early Stage | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FI (Completed) SK (Completed) SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-003996-23 | Sponsor Protocol Number: SAKK08/16 | Start Date*: 2017-08-29 | |||||||||||
| Sponsor Name:SAKK | |||||||||||||
| Full Title: ODM-201 maintenance therapy in patients with metastatic castration resistant prostate cancer (mCRPC) previously treated with one novel hormonal agent first line and nonprogressive disease after sec... | |||||||||||||
| Medical condition: Metastatic castration resistant prostate cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male | ||||||||||||
| Trial protocol: IT (Prematurely Ended) ES (Ongoing) FR (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-004986-38 | Sponsor Protocol Number: 337HNAS20011 | Start Date*: 2022-01-04 | |||||||||||
| Sponsor Name:Inventiva S.A. | |||||||||||||
| Full Title: A randomised, double-blind, placebo-controlled, multicentre, Phase 3 study evaluating long-term efficacy and safety of lanifibranor in adult patients with non-cirrhotic non-alcoholic steatohepatiti... | |||||||||||||
| Medical condition: Non-alcoholic Steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Trial now transitioned) DE (Trial now transitioned) ES (Ongoing) AT (Completed) HU (Trial now transitioned) BG (Trial now transitioned) IT (Trial now transitioned) NL (Trial now transitioned) PL (Trial now transitioned) BE (Trial now transitioned) PT (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
